Hemab Therapeutics Holdings, Inc.

COAG

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0002114044

SEC filings (opens in a new tab)

Insider trades, last 90 days

None

No open-market purchases or sales were filed in the last 90 days.

View insider trades

13F holders, Q2 2026

56

+56 vs. Q1 2026
Total value $1.33B

View 13F holders

Superinvestors holding COAG

1

At the end of Q2 2026

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by COAG insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Jun 17, 20266:24 PM ET	Jun 15 – Jun 16, 2026	RA Capital Healthcare Fund LP and 3 others10% Owner	PPurchaseCommon Stock	+67.67K	$24.9718	+$1.69M	6.44M	+1.1%	SEC
May 21, 20264:20 PM ET	May 19 – May 20, 2026	RA Capital Healthcare Fund LP and 3 others10% Owner	PPurchaseCommon Stock	+4.8K	$24.9638	+$119.78K	6.38M	+0.1%	SEC
May 14, 20265:21 PM ET	May 12, 2026	RA Capital Healthcare Fund LP and 3 others10% Owner	PPurchaseCommon Stock	+6.39K	$24.90	+$159.04K	6.37M	+0.1%	SEC
May 11, 20265:44 PM ET	May 7 – May 11, 2026	RA Capital Healthcare Fund LP and 3 others10% Owner	PPurchaseCommon Stock	+51.26K	$24.7492	+$1.27M	6.37M	+0.8%	SEC
May 6, 20267:16 PM ET	May 4 – May 6, 2026	RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner	PPurchaseCommon Stock	+2.84M	$18.3856	+$52.22M	6.31M	+81.8%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in COAG at the end of Q2 2026.

Institutions holding COAG in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
RA CAPITAL MANAGEMENT, L.P.	7,808,627	$286.81M	2.49%	+7,808,627	New
Novo Holdings A/S	4,180,550	$153.55M	8.92%	+4,180,550	New
FMR LLC	3,697,837	$135.82M	0.01%	+3,697,837	New
Capital International Investors	3,603,876	$132.37M	0.03%	+3,603,876	New
Deep Track Capital, LP	3,602,093	$132.3M	1.95%	+3,602,093	New